查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1589463

糖尿病注射笔市场：按产品、应用和分销管道划分 - 全球预测 2025-2030 年

Diabetes Injection Pens Market by Product (Insulin Pens, Pen Needles), Usage (Disposable, Reusable), Distribution Channel - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 195 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年糖尿病注射笔市场价值为165亿美元，预计到2024年将达到174.6亿美元，复合年增长率为5.87%，到2030年将达到246.1亿美元。

糖尿病注射笔市场包括用于注射胰岛素和其他糖尿病药物的设备。这些笔提供准确的剂量、易于使用并提高糖尿病管理所需的依从性。全球范围内糖尿病盛行率的上升、人口老化以及患者对与传统注射器相比侵入性较小的给药方法的偏好推动了对这些注射笔的需求。根据应用，这些笔广泛被 1 型和 2 型糖尿病患者使用，分为一次性和可重复使用类型。典型的最终使用者包括医院、诊所和家庭护理机构。市场开拓受到多种因素的影响，例如笔技术的进步提高了易用性和准确性，提高了消费者对糖尿病管理的认识，以及扩大新兴市场的医疗基础设施。最近的商机来自技术集成，例如支援蓝牙的笔，可以与行动应用程式同步以追踪剂量模式，为公司创造利润丰厚的前景。此外，能够输送生物药品的笔的开发代表了技术创新的新途径。然而，与糖尿病治疗相关的高成本、严格的监管要求以及对针头恐惧症和潜在副作用的担忧是市场成长的挑战。为了保持竞争力，企业应该专注于开发具有成本效益、易于使用的整合式数位解决方案的设备。投资无针选择和生技药品的研究也可以开拓新的收益来源。儘管存在这些挑战，但随着企业透过产品多元化和策略联盟抓住机会，市场预计将稳定成长。随着市场的不断发展，客製化和采用以患者为中心的解决方案将是占领开拓细分市场和推动业务成长的关键。整体而言，市场竞争激烈，快速发展预示着巨大的扩张和创新潜力。

主要市场统计
基准年[2023] 165亿美元
预测年份 [2024] 174.6亿美元
预测年份 [2030] 246.1亿美元
复合年增长率（%） 5.87%

市场动态：快速发展的糖尿病注射笔市场的关键市场洞察

供需的动态交互作用正在改变糖尿病注射笔市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 全球糖尿病患者数量不断增加
    • 智慧胰岛素笔需求
    • 扩大可重复使用的糖尿病注射笔的采用
  • 市场限制因素
    • 使用笔使用某些类型胰岛素的限制
  • 市场机会
    • 透过电子商务轻鬆获得和便利
    • 先进糖尿病注射笔简介
  • 市场挑战
    • 使用不当有感染风险

波特五力：驾驭糖尿病注射笔市场的策略工具

波特的五力框架是了解糖尿病注射笔市场竞争格局的关键工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解糖尿病注射笔市场的外部影响

外部宏观环境因素在塑造糖尿病注射笔市场的绩效动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解糖尿病注射笔市场的竞争格局

对糖尿病注射笔市场的详细市场占有率分析可以对供应商的业绩进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵糖尿病注射笔市场供应商的绩效评估

FPNV 定位矩阵是评估糖尿病注射笔市场供应商的关键工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，以确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议描绘了糖尿病注射笔市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，对糖尿病注射笔市场的策略分析至关重要。透过考虑关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球糖尿病的盛行率正在上升
      • 智慧胰岛素笔需求
      • 更多采用可重复使用的糖尿病注射笔
    • 抑制因素
      • 透过笔使用某些类型的胰岛素时的限制
    • 机会
      • 透过电子商务管道轻鬆获得且方便
      • 先进糖尿病注射笔简介
    • 任务
      • 使用不当有感染风险
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章糖尿病注射笔市场：副产品

  • 胰岛素笔
  • 笔针

第七章按应用分列的糖尿病注射笔市场

  • 一次性的
  • 可重复使用的

第八章糖尿病注射笔市场：依通路分类

  • 糖尿病诊所
  • 医院药房
  • 网上销售
  • 零售药房

第九章北美和南美糖尿病注射笔市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太地区糖尿病注射笔市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章欧洲、中东和非洲糖尿病注射市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AstraZeneca PLC
  • Becton, Dickinson, and Company
  • Biocon Limited
  • Dexcom Inc.
  • Eli Lilly and Company
  • F. Hoffmann-La Roche AG
  • Haselmeier GmbH
  • Jiangsu Delfu Medical Device Co., Ltd.
  • Medtronic PLC
  • Merck KGaA
  • Novartis AG
  • Novo Nordisk A/S
  • Owen Mumford Limited
  • Pfizer Inc.
  • Sanofi SA
  • Ypsomed Holding AG
Product Code: MRR-4348D129FA0E

The Diabetes Injection Pens Market was valued at USD 16.50 billion in 2023, expected to reach USD 17.46 billion in 2024, and is projected to grow at a CAGR of 5.87%, to USD 24.61 billion by 2030.

The market for diabetes injection pens encompasses devices used to administer insulin and other diabetes medications. These pens offer precise dosing, ease of use, and increased compliance, crucial for diabetes management. The necessity for these pens is driven by the rising prevalence of diabetes globally, an aging population, and patient preference for less invasive administration methods compared to traditional syringes. Application-wise, these pens are widely used by individuals with type 1 and type 2 diabetes and are available in disposable and reusable forms. Key end-users include hospitals, clinics, and homecare settings. Market growth is influenced by factors such as advancements in pen technology, which improve ease of use and accuracy, increasing consumer awareness about diabetes management, and expanding healthcare infrastructure in developing regions. Recent opportunities are powered by technological integration, such as Bluetooth-enabled pens that sync with mobile apps to track dosing patterns, providing a lucrative prospect for companies. Additionally, the development of pens capable of delivering biopharmaceuticals presents new avenues for innovation. However, market growth is challenged by high costs associated with diabetes treatment, stringent regulatory requirements, and concerns over needle phobia and potential side effects. Companies should focus on creating cost-effective, user-friendly devices with integrated digital solutions to remain competitive. Investing in research for needle-free options and biologics delivery can also open new revenue streams. Despite these challenges, the market is expected to see steady growth as companies harness opportunities through product diversification and strategic partnerships. As the market continues to evolve, embracing customization and patient-centric solutions will be key in capturing untapped segments and driving business growth. Overall, the market is competitive, with rapid advancements heralding significant potential for expansion and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 16.50 billion
Estimated Year [2024] USD 17.46 billion
Forecast Year [2030] USD 24.61 billion
CAGR (%) 5.87%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Diabetes Injection Pens Market

The Diabetes Injection Pens Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of diabetic patients worldwide
    • Demand for intelligent insulin pen
    • Growth in adoption of reusable diabetes injection pen
  • Market Restraints
    • Limitation on using certain types of insulin through a pen
  • Market Opportunities
    • Easy availability and convenience through e-commerce channel
    • Introduction of advanced diabetes injection pens
  • Market Challenges
    • Risk of infection due to improper use

Porter's Five Forces: A Strategic Tool for Navigating the Diabetes Injection Pens Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Diabetes Injection Pens Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Diabetes Injection Pens Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Diabetes Injection Pens Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Diabetes Injection Pens Market

A detailed market share analysis in the Diabetes Injection Pens Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Diabetes Injection Pens Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Diabetes Injection Pens Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Diabetes Injection Pens Market

A strategic analysis of the Diabetes Injection Pens Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Diabetes Injection Pens Market, highlighting leading vendors and their innovative profiles. These include AstraZeneca PLC, Becton, Dickinson, and Company, Biocon Limited, Dexcom Inc., Eli Lilly and Company, F. Hoffmann-La Roche AG, Haselmeier GmbH, Jiangsu Delfu Medical Device Co., Ltd., Medtronic PLC, Merck KGaA, Novartis AG, Novo Nordisk A/S, Owen Mumford Limited, Pfizer Inc., Sanofi S.A., and Ypsomed Holding AG.

Market Segmentation & Coverage

This research report categorizes the Diabetes Injection Pens Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Insulin Pens and Pen Needles.
  • Based on Usage, market is studied across Disposable and Reusable.
  • Based on Distribution Channel, market is studied across Diabetes Clinics, Hospital Pharmacy, Online Sales, and Retail Pharmacy.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of diabetic patients worldwide
      • 5.1.1.2. Demand for intelligent insulin pen
      • 5.1.1.3. Growth in adoption of reusable diabetes injection pen
    • 5.1.2. Restraints
      • 5.1.2.1. Limitation on using certain types of insulin through a pen
    • 5.1.3. Opportunities
      • 5.1.3.1. Easy availability and convenience through e-commerce channel
      • 5.1.3.2. Introduction of advanced diabetes injection pens
    • 5.1.4. Challenges
      • 5.1.4.1. Risk of infection due to improper use
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Diabetes Injection Pens Market, by Product

  • 6.1. Introduction
  • 6.2. Insulin Pens
  • 6.3. Pen Needles

7. Diabetes Injection Pens Market, by Usage

  • 7.1. Introduction
  • 7.2. Disposable
  • 7.3. Reusable

8. Diabetes Injection Pens Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Diabetes Clinics
  • 8.3. Hospital Pharmacy
  • 8.4. Online Sales
  • 8.5. Retail Pharmacy

9. Americas Diabetes Injection Pens Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Diabetes Injection Pens Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Diabetes Injection Pens Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AstraZeneca PLC
  • 2. Becton, Dickinson, and Company
  • 3. Biocon Limited
  • 4. Dexcom Inc.
  • 5. Eli Lilly and Company
  • 6. F. Hoffmann-La Roche AG
  • 7. Haselmeier GmbH
  • 8. Jiangsu Delfu Medical Device Co., Ltd.
  • 9. Medtronic PLC
  • 10. Merck KGaA
  • 11. Novartis AG
  • 12. Novo Nordisk A/S
  • 13. Owen Mumford Limited
  • 14. Pfizer Inc.
  • 15. Sanofi S.A.
  • 16. Ypsomed Holding AG

LIST OF FIGURES

  • FIGURE 1. DIABETES INJECTION PENS MARKET RESEARCH PROCESS
  • FIGURE 2. DIABETES INJECTION PENS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. DIABETES INJECTION PENS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL DIABETES INJECTION PENS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. DIABETES INJECTION PENS MARKET DYNAMICS
  • TABLE 7. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY INSULIN PENS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY PEN NEEDLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY DIABETES CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL DIABETES INJECTION PENS MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES DIABETES INJECTION PENS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA DIABETES INJECTION PENS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY USAGE, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM DIABETES INJECTION PENS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. DIABETES INJECTION PENS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 146. DIABETES INJECTION PENS MARKET, FPNV POSITIONING MATRIX, 2023